Top Growth Companies With High Insider Ownership On Euronext Paris In August 2024
Reviewed by Simply Wall St
In recent weeks, the French stock market has faced significant volatility, influenced by weak U.S. economic data and broader concerns about global growth. Despite these challenges, certain growth companies with high insider ownership on Euronext Paris continue to attract attention for their potential resilience and long-term prospects. When evaluating stocks in this environment, it's crucial to consider companies where insiders have substantial ownership. This often indicates a strong alignment of interests between management and shareholders, which can be particularly valuable during periods of market uncertainty.
Top 10 Growth Companies With High Insider Ownership In France
| Name | Insider Ownership | Earnings Growth |
| Groupe OKwind Société anonyme (ENXTPA:ALOKW) | 24.8% | 36% |
| VusionGroup (ENXTPA:VU) | 13.4% | 25.7% |
| Adocia (ENXTPA:ADOC) | 11.9% | 63% |
| Icape Holding (ENXTPA:ALICA) | 30.2% | 35.1% |
| Arcure (ENXTPA:ALCUR) | 21.4% | 27.5% |
| STIF Société anonyme (ENXTPA:ALSTI) | 16.4% | 28.5% |
| La Française de l'Energie (ENXTPA:FDE) | 19.9% | 31.9% |
| Munic (ENXTPA:ALMUN) | 29.4% | 149.2% |
| OSE Immunotherapeutics (ENXTPA:OSE) | 25.6% | 5.9% |
| MedinCell (ENXTPA:MEDCL) | 15.8% | 71.1% |
We'll examine a selection from our screener results.
Lectra (ENXTPA:LSS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Lectra SA provides industrial intelligence solutions for the fashion, automotive, and furniture markets across Northern Europe, Southern Europe, the Americas, and the Asia Pacific with a market cap of €965.92 million.
Operations: The company's revenue segments are: Americas (€172.65 million), Asia-Pacific (€118.54 million), and Segment Adjustment (€209.13 million).
Insider Ownership: 19.6%
Earnings Growth Forecast: 32.6% p.a.
Lectra SA, a growth company with high insider ownership in France, reported half-year sales of €262.29 million, up from €239.55 million last year. However, net income decreased to €12.51 million from €14.47 million. Despite this dip in earnings per share to €0.33 from €0.38, the company is trading at good value compared to peers and industry standards and is forecasted for significant annual earnings growth of 32.6%, outpacing the French market's 12.2%.
- Navigate through the intricacies of Lectra with our comprehensive analyst estimates report here.
- The analysis detailed in our Lectra valuation report hints at an deflated share price compared to its estimated value.
MedinCell (ENXTPA:MEDCL)
Simply Wall St Growth Rating: ★★★★★☆
Overview: MedinCell S.A., a pharmaceutical company with a market cap of €450.86M, develops long-acting injectables across various therapeutic areas in France.
Operations: MedinCell's revenue segment primarily consists of its pharmaceuticals division, generating €11.95 million.
Insider Ownership: 15.8%
Earnings Growth Forecast: 71.1% p.a.
MedinCell, a French growth company with high insider ownership, reported FY2024 revenue of €11.95 million and a net loss of €25.04 million, showing improvement from the previous year. The company's Phase 3 trial for F14 did not meet its primary endpoint but showed promising secondary outcomes in pain management and knee function post-TKR. MedinCell's revenue is forecast to grow at 44.7% annually, and it is expected to become profitable within three years.
- Delve into the full analysis future growth report here for a deeper understanding of MedinCell.
- Insights from our recent valuation report point to the potential overvaluation of MedinCell shares in the market.
VusionGroup (ENXTPA:VU)
Simply Wall St Growth Rating: ★★★★★★
Overview: VusionGroup S.A. offers digitalization solutions for commerce across Europe, Asia, and North America, with a market cap of €2.15 billion.
Operations: VusionGroup S.A. generates revenue primarily from installing and maintaining electronic shelf labels, amounting to €801.96 million.
Insider Ownership: 13.4%
Earnings Growth Forecast: 25.7% p.a.
VusionGroup, a French growth company with high insider ownership, is forecast to achieve significant earnings growth of 25.7% annually, outpacing the French market. Revenue is expected to grow at 21.3% per year, driven by recent partnerships like Ace Hardware and Hy-Vee. These collaborations enhance store operations through advanced digital shelf label technology and IoT solutions, improving efficiency and customer experience while positioning VusionGroup for sustained growth in the retail sector.
- Click to explore a detailed breakdown of our findings in VusionGroup's earnings growth report.
- According our valuation report, there's an indication that VusionGroup's share price might be on the expensive side.
Next Steps
- Navigate through the entire inventory of 23 Fast Growing Euronext Paris Companies With High Insider Ownership here.
- Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
- Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
Contemplating Other Strategies?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ENXTPA:MEDCL
MedinCell
A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.
High growth potential and slightly overvalued.
